Dynamics of ’Technegas’ deposited in the lung

Nuclear Medicine Communications

Volumn 22, Issue 4, 2001, Pages 383-387

  Xu, J H ^a   Moonen, M ^b   Johansson, A ^b   Bake, B ^b  

^a Institute of Heart and Lung Diseases   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Pulmonary emphysema; Radionuclide imaging; Ventilation

Indexed keywords

PERTECHNETIC ACID TC 99M; TECHNEGAS; TECHNETIUM 99M;

ADULT; AEROSOL; AGED; ARTICLE; CLEARANCE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTAMINATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DYNAMICS; FEMALE; FORCED EXPIRATORY VOLUME; GENERATOR; HUMAN; INHALATION; ISOTOPE LABELING; LUNG DEPOSIT; LUNG EMPHYSEMA; LUNG SCINTISCANNING; LUNG VENTILATION; MALE; VITAL CAPACITY;

ADULT; AGED; DATA INTERPRETATION, STATISTICAL; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; REFERENCE VALUES; SODIUM PERTECHNETATE TC 99M; SUPINE POSITION; TIME FACTORS; TISSUE DISTRIBUTION; VITAL CAPACITY;

EID: 0035073724     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200104000-00006     Document Type: Article

References (13)

1. James JM, Testa HJ. The use of 99mTc-Technegas in the investigation of patients with pulmonary thromboembolism. Nucl Med Commun 1995; 16: 802-810.
2. Sasaki Y, Imai T, Shinkai T, et al. Estimation of regional lung function in interstitial pulmonary disease using 99mTc-technegas and 99mTc-macroaggregated albumin single-photon emission tomography. Eur J Nucl Med 1998; 25: 1623-1629.
3. Satoh K, Takahashi K, Kobayashi T, et al. The usefulness of 99mTc-Technegas scintigraphy for diagnosing pulmonary impairment caused by pulmonary emphysema. Acta Med Okayama 1998; 52: 97-103.
4. Xu JH, Moonen M, Johansson A, Bake B. Inhomogeneity in planar ventilation scintigraphy of emphysematous patients. Clin Physiol 1998; 18: 435-440.
5. James JM, Herman KJ, Lloyd JJ, et al. Evaluation of 99mTc Technegas ventilation scintigraphy in the diagnosis of pulmonary embolism. Br J Radiol 1991; 64: 711-719.
6. Isawa T, Teshima T, Anazawa Y, Miki M, Soni PS. Technegas versus krypton-81m gas as an inhalation agent. Comparison of pulmonary distribution at total lung capacity. Clin Nucl Med 1994; 19: 1085-1090.
7. Burch WM, Sullivan PJ, McLaren CJ. Technegas - a new ventilation agent for lung scanning. Nucl Med Commun 1986; 7: 865-871.
8. Isawa T, Teshima T, Anazawa Y, Miki M, Motomiya M. Technegas for inhalation lung imaging. Nucl Med Commun 1991; 12: 47-55.
9. Burch WM. Evidence for the long-term biological distribution of Technegas particles. Nucl Med Commun 1993; 14: 559-561.
10. Xu JH, Moonen M, Johansson A, Bake B. Distribution of ventilation to perfusion ratios analysed in planar scintigrams of emphysematous patients. Clin Physiol 2000; 20: 89-94.
11. Monaghan P, Provan I, Murray C, et al. An improved radionuclide technique for the detection of altered pulmonary permeability. J Nucl Med 1991; 32: 1945-1949.
12. Isawa T, Teshima T, Anazawa Y, Miki M, Mahmud AM. Inhalation of pertechnegas: similar clearance from the lungs to that of inhaled pertechnetate aerosol. Nucl Med Commun 1995; 16: 741-746.
13. Scalzetti EM, Gagne GM. The transition from technegas to pertechnegas. J Nucl Med 1995; 36: 267-269.